Proteomics, Metabolomics, Interactomics and Systems Biology

Reviews on New Drug Targets in Age-Related Disorders

Part II

Editors: Guest, Paul C. (Ed.)

Free Preview
  • Describes potential novel drug targets for age-related disorders
    Reviews studies and current research on age-related disorders worldwide
    Discusses developments for new therapeutic approaches to age-related disorders

Buy this book

eBook $139.00
price for USA in USD
  • ISBN 978-3-030-55035-6
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $179.99
price for USA in USD
  • ISBN 978-3-030-55034-9
  • Free shipping for individuals worldwide
  • Institutional customers should get in touch with their account manager
  • Covid-19 shipping restrictions
  • Usually ready to be dispatched within 3 to 5 business days, if in stock
About this book

Aging is an inevitable part of life, and is becoming a worldwide social, economic and health problem due to the fact that an increasing proportion of individuals in the advanced age category have a higher probability of developing age-related disorders. New therapeutic approaches are still in need to decrease or slow the effects of such diseases in this aging society. Advances in ‘omic technologies such as genomics, transcriptomics, proteomics and metabolomics have significantly advanced our understanding of diseases in multiple medical areas. It is hoped that emerging hits from these analyses might be prioritized for further screening as potential novel drug targets for increasing the human healthspan in line with the lifespan, which will in turn lead to new therapeutic strategies and drug development projects by the pharmaceutical industry. This new book presents a series of reviews describing studies which have resulted in the identification of potential new drug targets for age-related disorders. Much of this information has come from ‘omic comparisons of healthy and disease states or from testing the effects of potential new therapeutic approaches. Each chapter will be presented in the context of specific chronic diseases or different therapeutic strategies, providing important information on disease mechanisms related to the aging process. This book will be of interest to researchers in the areas of aging and chronic disease, as well as clinical scientists, physicians, and major drug companies. With contributors from Australia, Brazil, Canada, France, Germany, India, Iran, Iraq, South Africa, South Korea, Thailand, Ukraine, United Kingdom, United States of America, Uruguay and Vietnam, this is a timely follow up to Guest’s previous book Reviews on New Drug Targets in Age-Related Disorders.

About the authors

Dr. Paul C. Guest, Ph.D, is a scientific researcher/writer with 37 years of experience in the fields of metabolic and neurological disorders. This includes experience in both academia and the pharmaceutical industry with the majority of time spent at the University of Cambridge and Merck Sharp & Dohme in the United Kingdom. He has also been affiliated with the University of Campinas in Sao Paulo Brazil since 2015, still focused on advancing the field of biomarkers for neurological disorders such as schizophrenia and Alzheimer’s disease, and more recently in the area of anti-aging research.

Table of contents (17 chapters)

Table of contents (17 chapters)
  • New Therapeutic Approaches and Biomarkers for Increased Healthspan

    Pages 1-13

    Guest, Paul C.

  • Targeting Cancer Metabolism and Current Anti-Cancer Drugs

    Pages 15-48

    Sukjoi, Witchuda (et al.)

  • A Review of Monoclonal Antibody-Based Treatments in Non-small Cell Lung Cancer

    Pages 49-64

    Panahi, Yunes (et al.)

  • Parkinson’s Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature

    Pages 65-76

    Das, Biswadeep (et al.)

  • Targeted Treatment of Age-Related Fibromyalgia with Supplemental Coenzyme Q10

    Pages 77-85

    Hargreaves, Iain P. (et al.)

Buy this book

eBook $139.00
price for USA in USD
  • ISBN 978-3-030-55035-6
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $179.99
price for USA in USD
  • ISBN 978-3-030-55034-9
  • Free shipping for individuals worldwide
  • Institutional customers should get in touch with their account manager
  • Covid-19 shipping restrictions
  • Usually ready to be dispatched within 3 to 5 business days, if in stock
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Reviews on New Drug Targets in Age-Related Disorders
Book Subtitle
Part II
Editors
  • Paul C. Guest
Series Title
Proteomics, Metabolomics, Interactomics and Systems Biology
Series Volume
1286
Copyright
2021
Publisher
Springer International Publishing
Copyright Holder
The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
eBook ISBN
978-3-030-55035-6
DOI
10.1007/978-3-030-55035-6
Hardcover ISBN
978-3-030-55034-9
Series ISSN
2730-6216
Edition Number
1
Number of Pages
VIII, 272
Number of Illustrations
10 b/w illustrations, 31 illustrations in colour
Topics